Zacks Investment Research downgraded shares of UNIVL AMERICAN (UAM) from OUTPERFORM to NEUTRAL on August 01, 2012, with a target price of $11.50.
Universal American Corp. offers a range of health insurance and managed care products and services, and is dedicated to working collaboratively with doctors, pharmacists and other caring professionals to improve the health and well-being of its members. It offers these services primarily to the senior population. The Company's principal health insurance products for the senior market are Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. Universal American also provides administrative services for senior market insurance and non-insurance programs to both affiliated and unaffiliated insurance companies and prescription benefit management services to state pharmacy assistance programs through a number of group contracts. Formerly known as Universal American Financial Corp., the company is headquartered in Rye Brook, New York.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on UNIVL AMERICAN (UAM),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment